Nimotuzumab Concurrent with Gemcitabine as First-Line Treatment of Locally Advanced or Metastatic Pancreatic Adenocarcinoma

Figure 4

The Kaplan-Meier curves for progression-free survival in first-line treatment patients and according to disease status at inclusion. SD: standard deviation; CI: confidence interval.